ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Amifostine For SCCHN

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00095927
Recruitment Status : Completed
First Posted : November 9, 2004
Last Update Posted : January 4, 2017
Sponsor:
Collaborators:
National Cancer Institute (NCI)
MedImmune LLC
AstraZeneca
Information provided by (Responsible Party):
Robert I. Haddad, MD, Dana-Farber Cancer Institute